Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Image
… a smaller proportion of around 10% or less with fatigue. Skin reactions like a local burn were rarely seen as well. A …
Post - Dr West -
… cell lung cancer (NSCLC), as well as in multiple other cancers. Why is this? Twenty years ago, patients who … acute toxicity of PCI was low in this study (hair loss, skin reactions and fatigue are most common), we don’t yet …
Post - mpinder -
… this agent in oncology over the past several years. Rash/skin toxicity (worse than the EGFR tyrosine kinase inhibitors …
Post - Dr West -
… you actually instill a little bit of medicine under the skin — this medicine will be there and it acts very quickly …
Post - gracevideo -
… CT guidance, in an area where there is fluid beneath the skin, and fluid is then removed. A thoracentesis can be … is another major issue to tackle. For some responsive cancers, such as lymphomas and SCLC, systemic therapy (such … is often enough to also treat the effusion. Some breast cancers, and also some NSCLCs as well, may be responsive …
Post - Dr West -
… approach in which a needle probe is inserted through the skin, under visual guidance using a CT or ultrasound, to go …
Post - Dr West -
… has the appeal of not only being active in cell lines from cancers with an EGFR activating mutation, but also apparently … 45 mg daily. The most problematic of these were diarrhea, skin rash, mouth sores, diminished appetite, and a hand-foot …
Post - Dr West -